Arvee Laboratories Ltd

Arvee Laboratories

About the Company:

Arvee Laboratories (Incorporated on January 27, 2012) started its work by trading in specialty chemicals by getting manufacturing done on job work basis from Skylead Chemicals Limited and Skylink Chemicals Private Limited.

On April 20, 2013, Company bought land, building and machineries from Skylink Chemicals Private Limited who were engaged in manufacturing of specialty chemicals which fostered their growth and expansion. Since 2013 Arvee Laboratories has been making additions to its plant & machinery, expanding capacities and modernizing its building.

Company started its operations with an aim to become a leader & frontrunner in chemical industry by providing the best and innovative quality chemical products.

Company is mainly engaged in manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates.Company’s product portfolio consists of wide range of specialty chemical products which differentiate them from other companies. With a wide product portfolio, company is able to cater to the demand of both domestic as well as international markets.

Company also aims at diversifying the activity of manufacturing specialty chemicals like Dimethyl 5-Nitroisphthalate, 2-Thiophene- Carboxaldehyde, 2-Acetyl Thiophene, Lithium Sulpho Isopthalic Acid-LiSIPA, etc that cater to the needs and demands of other businesses in India and overseas.

Major Events for the Company in the Year 2017:

Company’s plant was inspected and approved by an American X-ray contrast media manufacturer who has the largest market share in the world and started of pilot trials with the the company.

Received order for commercial trials of Nitro Derivatives of Isophthalic acid from the largest manufacturer of X-ray contrast media manufacturer in the world.

Major Domestic Clients & Revenue Contribution: (in Lakhs)

Geographic Revenue Details: (in Lakhs)

Management Team:

  1. Mr.Shalin Sudhakarbhai Patel (Designation: Managing Director)
  2. Mr.Shalin Bharat Chokshi (Designation: Whole- Time Director)
  3. Mr. Saumil Bharatbhai Chokshi (Designation: Non- Executive Director)


Promoters Average Acquisition Cost:

Name of the Promoter No. of Shares held Average Acquisition Cost (in Rs.)
Mr. Shalin Sudhakarbhai Patel 16,90,000 10.00
Mr. Shalin Bharat Chokshi 6,69,000 10.00


Promoters Stake Pre & Post Issue:

Shareholder Name Pre Issue Stake (%) Post Issue Stake
Shalin Sudhakarbhai Patel 41.73% 30.67%
Shalin Bharat Chokshi 16.53% 12.14%
Promoters Group Entities            41.74%           30.7%
Total 100% 73.50%


Objectives of the Issue:

  • Re-payment of Unsecured Loans of Promoters.
  • Issue Expenses.


Fund Utilization:

Particulars Amount (Rs. in Crores)
Re-payment of Unsecured Loans of Promoters 8.40
Issue Expenses 0.50
Net Proceeds 8.9 cr


Financials of the Company:

(in Crores) FY 13 FY 14 FY 15 FY 16 FY 17 30th Sept 17
Revenue  3.55  11.84  13.05 26.92   34.94  19.80
Net Profit  0.043  0.018  (-1.64)  0.18  1.55  0.31


Valuation of Peer Group Companies:

Company Name Face Value EPS PE Ratio
Arvee Laboratories Ltd 10 3.83 15.93
Transpek Industry Limited 10 50.90 21.37
Thirumalai Chemicals Limited 10 73.71 21.57
Fineotex Chemical Limited 2 1.43 19.97


IPO Details:

Details Info
Issue Opens on 9th February 2018
Issue Closes on:. 14th February 2018
Issue Price Rs.61
Face Value Rs.10
Minimum Lot 2000
Minimum Investment Rs.1,22,000
Issue Constitutes 26.50%
Issue Size Rs.8.9 cr
Market Cap Rs.33.61 cr
Listing at NSE SME
Total Equity Shares Offered (fresh) 14,60,000
Equity Shares Prior to the Issue 40,50,000
Equity Shares after the issue 55,10,000


IPO Valuation Parameters:

Earnings Per Share (EPS) Price To Earnings ratio (PE) Return on Net Worth (RoNW) Net Asset Value (NAV)
3.83 15.93 37% 10.36


Grey Market Premium :

Date IPO Price Band Grey Market premium
13/02/18 Arvee Laboratories Ltd 61  5 – 7


Subscription Details: (9/12/14 February 2018)

(Subscription-Category-Wise (no. of times) Till time : 06:00 PM) Shares Offered 9/2 12/2 14/2
HNI  6,92,000  0.00 1.91  2.17
Retail 6,92,000  1.39 1.63  3.61
Others 76,000  0.00  0.00  0.00
TOTAL 14,60,000  0.66 1.68  2.74


Markets Guruji Opinion:

IPO View Apply For: Expected listing Gain:
Subscribe Long Term 20%


Check IPO Allotment Status:

Bigshare Website (Click on the below link)


Company Contact Info:
49/3-B, Shyamal Row Houses,
100 Feet Road, Near Sanjay Tower, Satellite,
Ahmedabad- 380015, Gujarat, India
Tel: +91 79 26749036/37/38
Fax: +91 79 26742600


IPO Registrar Info:
1st Floor, Bharat Tin Works Building,
Opp. Vasant Oasis, Makwana Road,
Marol, Andheri East, Mumbai – 400059
Tel: +91 22 62638200
Fax: +91 22 62638299


Lead Manager to the Issue:
Unit No. 411, Fourth Floor, Pratap Bhavan,
5 Bahadur Shah Zafar Marg,
New Delhi-110002
Tel: +91 11 23739425-27
Fax: +91 11 23739424
Investor Grievance Email: